• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

GuideWell to Offer Livongo for Diabetes to Florida Blue Members

by Jasmine Pennic 10/12/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
GuideWell to Offer Livongo for Diabetes to Florida Blue Members

What You Should Know:

– GuideWell partners with Livongo to provide Florida Blue Members an end-to-end consumer-centric virtual care experience.

– Florida Blue will become one of the first health plans to provide health consumers with a single access point for whole-person care through Livongo and Teladoc’s best-in-class combined care experience.


Livongo, the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced a strategic partnership with GuideWell Mutual Holding Corporation (GuideWell), the parent to a family of forward-thinking companies focused on transforming health care. Florida Blue, a GuideWell subsidiary and the Blue Cross and Blue Shield plan of Florida, will in the future provide access to Livongo for Diabetes to select Members. GuideWell and Livongo plan to provide access to Livongo for Diabetes through GuideWell’s consumer engagement solution, Onlife Health, which helps guide health plan Members through their healthcare journey.

Florida Blue currently offers Teladoc Health’s virtual care program to its Members. In August, Teladoc Health and Livongo announced a planned merger agreement to create the global leader in consumer-centered virtual care.

Powering End-to-End Virtual Care Experience

Together, Teladoc Health and Livongo will offer select Florida Blue Members living with diabetes an end-to-end virtual care experience including connected devices, advanced data science, and telehealth – all via the Onlife Health platform. By integrating Teladoc Health’s best-in-class virtual care platform with Livongo’s highly sophisticated capabilities to aggregate data and provide useful insights to Florida Blue Members in real time, Florida Blue will become one of the first health plans in the nation to provide health consumers a single access point for whole-person care regardless of clinical situation, driving better health outcomes and lower costs.

“Offering tools and resources that improve access to care during the COVID-19 pandemic is critical,” said Pat Geraghty, President and CEO of GuideWell and Florida Blue. “Beyond the pandemic, the expectations of the consumer experience and care delivery will be forever changed. With Teladoc Health, we have experienced the clear benefits of virtual care and through a new partnership with Livongo, we are excited to offer additional resources for diabetes management that provides the tools for Members to manage their health on their terms.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Applied Health Signals, diabetes, Diabetes Management, Livongo, Partners, Teladoc, Virtual Care, Virtual Care Platform

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |